文献速递病毒性肝炎

微针贴片递送乙肝疫苗在恒河猴中的可行性与免疫应答研究

Feasibility of Hepatitis B Vaccination by Microneedle Patch: Cellular and Humoral Immunity Studies in Rhesus Macaques.
PubMed 文献 · J Infect Dis · 2019-01-01

结果显示dMNP递送AFV后8只中6只首剂后抗-HBs≥10 mIU/mL,且抗-HBs水平与HBsAg特异性T细胞产生的IFN-γ、IL-2和IL-4呈正相关。结论提示dMNP递送可诱导与人类血清保护相关的抗-HBs水平,可能适用于资源有限地区的乙肝疫苗出生剂次接种。

要点

  • dMNP递送AFV后8只中6只首剂即达抗-HBs≥10 mIU/mL。
  • dMNP递送可诱导HBsAg特异性T细胞产生IFN-γ、IL-2和IL-4。
  • 抗-HBs水平与HBsAg特异性Th1/Th2型细胞因子产生细胞正相关。

核心结论

  • dMNP递送AFV可在恒河猴中诱导与人类血清保护相关的抗-HBs水平,可能适用于资源有限地区的乙肝疫苗出生剂次接种。

研究设计与样本

  • 分析抗-HBs水平及HBsAg特异性T细胞应答。

主要发现

  • dMNP递送AFV组8只中6只首剂后抗-HBs≥10 mIU/mL。
  • dMNP递送AFV后检测到HBsAg特异性T细胞产生IFN-γ、IL-2和IL-4。
  • 所有抗-HBs阳性动物中,抗-HBs水平与产生HBsAg特异性IFN-γ、IL-2(Th1型)和IL-4(Th2型)的细胞呈统计学显著正相关。

临床怎么用

  • dMNP递送乙肝疫苗可能为资源有限地区提供无需针头的出生剂次接种选项。
  • 抗-HBs≥10 mIU/mL可作为血清保护参考指标,但需在人体试验中验证。

局限性

  • 研究仅为恒河猴临床前实验,样本量小(每组n=4),尚未在人体中验证。
  • 原文未报告长期保护持续时间及dMNP与肌注途径的直接统计比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study evaluated dissolvable microneedle patch (dMNP) delivery of hepatitis B vaccine in rhesus macaques and provides evidence that dMNP delivery elicits seroprotective anti-HBs levels comparable with human seroprotection, potentially useful for hepatitis B birth dose vaccination in resource-constrained regions. METHODS: Sixteen macaques were each vaccinated twice; they were treated in 4 groups, with dMNP delivery of AFV at 24 ± 8 µg (n = 4) or 48 ± 14 µg (n = 4), intramuscular injection of AFV (10 µg; n = 4), or intramuscular injection of AAV (10 µg; n = 4). Levels of antibody to hepatitis B surface antigen (HBsAg) (anti-HBs) and HBsAg-specific T-cell responses were analyzed. RESULTS: Six of 8 animals with dMNP delivery of AFV had anti-HBs levels ≥10 mIU/mL after the first vaccine dose. After dMNP delivery of AFV, interferon γ, interleukin 2, and interleukin 4 production by HBsAg-specific T cells was detected. A statistically significant positive correlation was detected between anti-HBs levels and cells producing HBsAg-specific interferon γ and interleukin 2 (T-helper 1-type cytokine) and interleukin 4 (T-helper 2-type cytokine) in all anti-HBs-positive animals. CONCLUSIONS: dMNP delivery of AFV can elicit seroprotective anti-HBs levels in rhesus macaques that are correlated with human seroprotection, and it could be particularly promising for birth dose delivery of hepatitis B vaccine in resource-constrained regions.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Choi YH, Perez-Cuevas MB, Kodani M, et al. Feasibility of Hepatitis B Vaccination by Microneedle Patch: Cellular and Humoral Immunity Studies in Rhesus Macaques. J Infect Dis. 2019. PMID: 31408163. doi:10.1093/infdis/jiz399

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。